-
1
-
-
74849100586
-
Gout
-
Richette P, Bardin T. Gout. Lancet 2010; 375 (9711): 318-28.
-
(2010)
Lancet
, vol.375
, Issue.9711
, pp. 318-328
-
-
Richette, P.1
Bardin, T.2
-
3
-
-
1542376013
-
Uric acid and diet-insights into the epidemic of cardiovascular dis-ease
-
Johnson RJ, Rideout BA. Uric acid and diet-insights into the epidemic of cardiovascular dis-ease. N Engl J Med 2004; 350: 1071-4.
-
(2004)
N Engl J Med
, vol.350
, pp. 1071-1074
-
-
Johnson, R.J.1
Rideout, B.A.2
-
4
-
-
34548759135
-
Gout: An update
-
Eggebeen AT. Gout: an update. Am Fam Physician 2007; 76(6): 801-8.
-
(2007)
Am Fam Physician
, vol.76
, Issue.6
, pp. 801-808
-
-
Eggebeen, A.T.1
-
6
-
-
34548759135
-
Gout: An update
-
Eggebeen AT. Gout: an update. Am Fam Physician 2007; 76(6): 801-8.
-
(2007)
Am Fam Physician
, vol.76
, Issue.6
, pp. 801-808
-
-
Eggebeen, A.T.1
-
7
-
-
0026592267
-
Two independent mutational events in the loss of urate oxidase during hominoid evolution
-
Wu XW, Muzny DM, Lee CC, Caskey CT. Two independent mutational events in the loss of urate oxidase during hominoid evolution. J Mol Evol 1992; 34: 78-84.
-
(1992)
J Mol Evol
, vol.34
, pp. 78-84
-
-
Wu, X.W.1
Muzny, D.M.2
Lee, C.C.3
Caskey, C.T.4
-
8
-
-
0019787519
-
Uric acid provides an antioxidant defense in humans against oxidant-and radical-caused aging and cancer: A hypothesis
-
Ames BN, Cathcart R, Schwiers E, Hochstein P. Uric acid provides an antioxidant defense in humans against oxidant-and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 1981; 78: 6858-62.
-
(1981)
Proc Natl Acad Sci USA
, vol.78
, pp. 6858-6862
-
-
Ames, B.N.1
Cathcart, R.2
Schwiers, E.3
Hochstein, P.4
-
9
-
-
54949100735
-
Uric Acid and Cardiovascular Risk
-
Feig DI, Kang DH, Johnson RJ. Uric Acid and Cardiovascular Risk. N Engl J Med 2008; 359(17): 1811-21.
-
(2008)
N Engl J Med
, vol.359
, Issue.17
, pp. 1811-1821
-
-
Feig, D.I.1
Kang, D.H.2
Johnson, R.J.3
-
10
-
-
0023634573
-
Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study
-
Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med 1987; 82: 421-6.
-
(1987)
Am J Med
, vol.82
, pp. 421-426
-
-
Campion, E.W.1
Glynn, R.J.2
DeLabry, L.O.3
-
11
-
-
13344281990
-
Gout epidemiology: Results from the UK General Practice Research Database 1990-1999
-
Mikuls TR, Farrar JT, Bilker WB, Fernandes S, Schumacher HR Jr, Saag KG. Gout epidemiology: results from the UK General Practice Research Database 1990-1999. Ann Rheum Dis 2005; 64(2): 267-72.
-
(2005)
Ann Rheum Dis
, vol.64
, Issue.2
, pp. 267-272
-
-
Mikuls, T.R.1
Farrar, J.T.2
Bilker, W.B.3
Fernandes, S.4
Schumacher Jr., H.R.5
Saag, K.G.6
-
13
-
-
80053497428
-
Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008
-
Zhu Y, Pandya BJ, Choi HK. Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007-2008. Arthritis Rheum 2011; 63(10): 3136-41.
-
(2011)
Arthritis Rheum
, vol.63
, Issue.10
, pp. 3136-3141
-
-
Zhu, Y.1
Pandya, B.J.2
Choi, H.K.3
-
15
-
-
34548142983
-
Independent impact of gout on mortality and risk for coronary heart disease
-
Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation 2007; 116: 894-900.
-
(2007)
Circulation
, vol.116
, pp. 894-900
-
-
Choi, H.K.1
Curhan, G.2
-
16
-
-
33846998296
-
Prevalence of the metabolic syndrome in patients with gout: The Third National Health and Nutrition Examination Survey
-
Choi HK, Ford ES, Li C, Curhan G. Prevalence of the metabolic syndrome in patients with gout: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2007; 57: 109-15.
-
(2007)
Arthritis Rheum
, vol.57
, pp. 109-115
-
-
Choi, H.K.1
Ford, E.S.2
Li, C.3
Curhan, G.4
-
18
-
-
44349151051
-
Long-term cardiovascular mortality among middle-aged men with gout
-
MRFIT Research Group
-
Krishnan E, Svendsen K, Neaton JD, Grandits G, Kuller LH. MRFIT Research Group. Long-term cardiovascular mortality among middle-aged men with gout. Arch Intern Med 2008; 168: 1104-10.
-
(2008)
Arch Intern Med
, vol.168
, pp. 1104-1110
-
-
Krishnan, E.1
Svendsen, K.2
Neaton, J.D.3
Grandits, G.4
Kuller, L.H.5
-
19
-
-
0038119701
-
Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?
-
Johnson RJ, Kang DH, Feig D, et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41(6): 1183-90.
-
(2003)
Hypertension
, vol.41
, Issue.6
, pp. 1183-1190
-
-
Johnson, R.J.1
Kang, D.H.2
Feig, D.3
-
20
-
-
0035993006
-
Gout, diet, and the insulin resistance syndrome
-
Fam AG. Gout, diet, and the insulin resistance syndrome. J Rheumatol 2002; 29: 1350-5.
-
(2002)
J Rheumatol
, vol.29
, pp. 1350-1355
-
-
Fam, A.G.1
-
21
-
-
0033936010
-
Beneficial effects of weight loss associated with moderate calorie/ carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: A pilot study
-
Dessein PH, Shipton EA, Stanwix AE, Joffe BI, Ramokgadi J. Beneficial effects of weight loss associated with moderate calorie/ carbohydrate restriction, and increased proportional intake of protein and unsaturated fat on serum urate and lipoprotein levels in gout: a pilot study. Ann Rheum Dis 2000; 59: 539-43.
-
(2000)
Ann Rheum Dis
, vol.59
, pp. 539-543
-
-
Dessein, P.H.1
Shipton, E.A.2
Stanwix, A.E.3
Joffe, B.I.4
Ramokgadi, J.5
-
22
-
-
0026325211
-
Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration
-
Facchini F, Chen YD, Hollenbeck CB, Reaven GM. Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration. JAMA 1991; 266(21): 3008-11.
-
(1991)
JAMA
, vol.266
, Issue.21
, pp. 3008-3011
-
-
Facchini, F.1
Chen, Y.D.2
Hollenbeck, C.B.3
Reaven, G.M.4
-
23
-
-
0030882289
-
Close correlation between visceral fat accumulation and uric acid metabolism in healthy men
-
Takahashi S, Yamamoto T, Tsutsumi Z, Moriwaki Y, Yamakita J, Higashino K. Close correlation between visceral fat accumulation and uric acid metabolism in healthy men. Metabolism 1997; 46 (10): 1162-5.
-
(1997)
Metabolism
, vol.46
, Issue.10
, pp. 1162-1165
-
-
Takahashi, S.1
Yamamoto, T.2
Tsutsumi, Z.3
Moriwaki, Y.4
Yamakita, J.5
Higashino, K.6
-
24
-
-
33751087771
-
Uric acid and the development of hypertension: The normative aging study
-
Perlstein TS, Gumieniak O, Williams GH, et al. Uric acid and the development of hypertension: the normative aging study. Hypertension 2006; 48(6): 1031-6.
-
(2006)
Hypertension
, vol.48
, Issue.6
, pp. 1031-1036
-
-
Perlstein, T.S.1
Gumieniak, O.2
Williams, G.H.3
-
25
-
-
34447318846
-
Association between serum uric acid and prehypertension among US adults
-
Syamala S, Li J, Shankar A. Association between serum uric acid and prehypertension among US adults. J Hypertens 2007; 25: 1583-9.
-
(2007)
J Hypertens
, vol.25
, pp. 1583-1589
-
-
Syamala, S.1
Li, J.2
Shankar, A.3
-
26
-
-
33646149386
-
Serum uric acid is associated with microal-buminuria in prehypertension
-
Lee JAE, Kim YG, Choi YH, Huh W, Kim DJ, Oh HY. Serum uric acid is associated with microal-buminuria in prehypertension. Hypertension 2006; 47: 962-7.
-
(2006)
Hypertension
, vol.47
, pp. 962-967
-
-
Lee, J.A.E.1
Kim, Y.G.2
Choi, Y.H.3
Huh, W.4
Kim, D.J.5
Oh, H.Y.6
-
27
-
-
0021949147
-
Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study
-
Brand FN, McGee DL, Kannel WB, Stokes J III, Castelli WP. Hyperuricemia as a risk factor of coronary heart disease: the Framingham Study. Am J Epidemiol 1985; 121: 11-8.
-
(1985)
Am J Epidemiol
, vol.121
, pp. 11-18
-
-
Brand, F.N.1
McGee, D.L.2
Kannel, W.B.3
Stokes III, J.4
Castelli, W.P.5
-
28
-
-
39749157632
-
Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: A preventive cardiology information system (PreCIS) database cohort study
-
Loachimescu AG, Brennan DM, Hoar BM, Hazen SL, Hoogwerf BJ. Serum uric acid is an independent predictor of all-cause mortality in patients at high risk of cardiovascular disease: a preventive cardiology information system (PreCIS) database cohort study. Arthritis Rheum 2008; 58(2): 623-30.
-
(2008)
Arthritis Rheum
, vol.58
, Issue.2
, pp. 623-630
-
-
Loachimescu, A.G.1
Brennan, D.M.2
Hoar, B.M.3
Hazen, S.L.4
Hoogwerf, B.J.5
-
29
-
-
84859792790
-
Prognostic Value of Uric Acid in Patients With Acute Coronary Syndromes
-
Feb 9. [Epub ahead of print]
-
Ndrepepa G, Braun S, Haase HU, et al. Prognostic Value of Uric Acid in Patients With Acute Coronary Syndromes. Am J Cardiol 2012 Feb 9. [Epub ahead of print]
-
(2012)
Am J Cardiol
-
-
Ndrepepa, G.1
Braun, S.2
Haase, H.U.3
-
30
-
-
33748608331
-
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)
-
Zhang W, Doherty M, Bardin T, et al. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006; 65: 1312-24.
-
(2006)
Ann Rheum Dis
, vol.65
, pp. 1312-1324
-
-
Zhang, W.1
Doherty, M.2
Bardin, T.3
-
31
-
-
75149194057
-
Update on gout: New therapeutic strategies and options
-
Terkeltaub R. Update on gout: new therapeutic strategies and options. Nat Rev Rheumatol 2010; 6(1): 30-8.
-
(2010)
Nat Rev Rheumatol
, vol.6
, Issue.1
, pp. 30-38
-
-
Terkeltaub, R.1
-
32
-
-
28944437578
-
Febuxostat compared with allopurinol in patients with hyperuricemia and gout
-
Becker MA, Schumacher HR Jr, Wortmann RL, et al. Febuxostat compared with allopurinol in patients with hyperuricemia and gout. N Engl J Med 2005; 353: 2450-61.
-
(2005)
N Engl J Med
, vol.353
, pp. 2450-2461
-
-
Becker, M.A.1
Schumacher Jr., H.R.2
Wortmann, R.L.3
-
33
-
-
56049101851
-
Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A 28-week, phase III, randomized, double-blind, parallel-group trial
-
Schumacher HR Jr, Becker MA, Wortmann RL, et al. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial. Arthritis Rheum 2008; 59: 1540-8.
-
(2008)
Arthritis Rheum
, vol.59
, pp. 1540-1548
-
-
Schumacher Jr., H.R.1
Becker, M.A.2
Wortmann, R.L.3
-
34
-
-
77953729446
-
The uratelowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: The CONFIRMS trial
-
Becker MA, Schumacher HR, Espinoza LR, et al. The uratelowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial. Arthritis Research & Therapy 2010; 12: R63.
-
(2010)
Arthritis Research & Therapy
, vol.12
-
-
Becker, M.A.1
Schumacher, H.R.2
Espinoza, L.R.3
-
35
-
-
74549197894
-
Febuxostat: A selective xanthineoxidase/ xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout
-
Ernst ME, Fravel MA. Febuxostat: a selective xanthineoxidase/ xanthine-dehydrogenase inhibitor for the management of hyperuricemia in adults with gout. Clin Ther 2009; 31(11): 2503-18.
-
(2009)
Clin Ther
, vol.31
, Issue.11
, pp. 2503-2518
-
-
Ernst, M.E.1
Fravel, M.A.2
-
36
-
-
47749120633
-
Therapeutic challenges in the management of gout in the elderly
-
Singh H, Torralba KD. Therapeutic challenges in the management of gout in the elderly. Geriatrics 2008; 63(7): 13-8.
-
(2008)
Geriatrics
, vol.63
, Issue.7
, pp. 13-18
-
-
Singh, H.1
Torralba, K.D.2
-
37
-
-
34848871559
-
Elderly-onset gout: A review
-
De Leonardis F, Govoni M, Colina M, Bruschi M, Trotta F. Elderly-onset gout: a review. Rheumatol Int 2007; 28(1): 1-6.
-
(2007)
Rheumatol Int
, vol.28
, Issue.1
, pp. 1-6
-
-
de Leonardis, F.1
Govoni, M.2
Colina, M.3
Bruschi, M.4
Trotta, F.5
|